These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15390084)

  • 1. Effective use of preparative chiral HPLC in a preclinical drug synthesis.
    Nelson TD; Welch CJ; Rosen JD; Smitrovich JH; Huffman MA; McNamara JM; Mathre DJ
    Chirality; 2004 Nov; 16(9):609-13. PubMed ID: 15390084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparative chromatographic resolution of racemates using HPLC and SFC in a pharmaceutical discovery environment.
    Miller L; Potter M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(1):230-6. PubMed ID: 18639504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparative separation and identification of derivatized beta-methylphenylalanine enantiomers by chiral SFC, HPLC and NMR for development of new peptide ligand mimetics in drug discovery.
    Nogle LM; Mann CW; Watts WL; Zhang Y
    J Pharm Biomed Anal; 2006 Mar; 40(4):901-9. PubMed ID: 16239092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of preparative batch HPLC, supercritical fluid chromatography, steady-state recycling, and simulated moving bed for the resolution of a racemic pharmaceutical intermediate.
    Yan TQ; Orihuela C; Swanson D
    Chirality; 2008 Feb; 20(2):139-46. PubMed ID: 18092299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective chromatography in drug discovery.
    Zhang Y; Wu DR; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2005 Apr; 10(8):571-7. PubMed ID: 15837600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc carbenoid-mediated chain extension: preparation of alpha,beta-unsaturated-gamma-keto esters and amides.
    Ronsheim MD; Zercher CK
    J Org Chem; 2003 May; 68(11):4535-8. PubMed ID: 12762764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid screening of enzymes for the enzymatic hydrolysis of chiral esters in drug discovery.
    Petucci C; Di L; McConnell O
    Chirality; 2007 Sep; 19(9):701-5. PubMed ID: 17575571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical fluid chromatography for the enantioseparation of pharmaceuticals.
    De Klerck K; Mangelings D; Vander Heyden Y
    J Pharm Biomed Anal; 2012 Oct; 69():77-92. PubMed ID: 22366324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel supercritical fluid chromatography/mass spectrometry system for high-throughput enantioselective optimization and separation.
    Zeng L; Xu R; Laskar DB; Kassel DB
    J Chromatogr A; 2007 Oct; 1169(1-2):193-204. PubMed ID: 17900596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Fit-for-purpose" development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel σ1 receptor agonist.
    Rossi D; Marra A; Rui M; Brambilla S; Juza M; Collina S
    J Pharm Biomed Anal; 2016 Jan; 118():363-369. PubMed ID: 26600118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and high throughput separation technologies--steady state recycling and supercritical fluid chromatography for chiral resolution of pharmaceutical intermediates.
    Yan TQ; Orihuela C
    J Chromatogr A; 2007 Jul; 1156(1-2):220-7. PubMed ID: 17449051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of quaternary stereocenters by efficient and practical conjugate additions to alpha,beta-unsaturated ketones with a chiral organic catalyst.
    Wu F; Li H; Hong R; Deng L
    Angew Chem Int Ed Engl; 2006 Jan; 45(6):947-50. PubMed ID: 16385604
    [No Abstract]   [Full Text] [Related]  

  • 15. Large scale chiral chromatography for the separation of an enantiomer to accelerate drug development.
    Hsu LC; Kim H; Yang X; Ross D
    Chirality; 2011 Apr; 23(4):361-6. PubMed ID: 21384442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced chromatographic resolution of amine enantiomers as carbobenzyloxy derivatives in high-performance liquid chromatography and supercritical fluid chromatography.
    Kraml CM; Zhou D; Byrne N; McConnell O
    J Chromatogr A; 2005 Dec; 1100(1):108-15. PubMed ID: 16197954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis of (+)-nephrosteranic acid, (+)-trans-cognac lactone, and (+)-trans-whisky lactone using a chiral cyclohexadienyl Ti compound.
    Schleth F; Vogler T; Harms K; Studer A
    Chemistry; 2004 Sep; 10(17):4171-85. PubMed ID: 15352100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving sensitivity in chiral supercritical fluid chromatography for analysis of active pharmaceutical ingredients.
    Helmy R; Biba M; Zang J; Mao B; Fogelman K; Vlachos V; Hosek P; Welch CJ
    Chirality; 2007 Nov; 19(10):787-92. PubMed ID: 17722016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supercritical fluid chromatography and steady-state recycling: phase appropriate technologies for the resolutions of pharmaceutical intermediates in the early drug development stage.
    Yan TQ; Orihuela C; Preston JP; Xia F
    Chirality; 2010 Nov; 22(10):922-8. PubMed ID: 20872668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
    Lin M; Tesconi M; Tischler M
    Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.